Vertebral Fracture: Diagnostic Difficulties of a Major Medical Problem.
Res. 2018 Apr;33(4):553-559. doi: 10.1002/jbmr.3404. Epub 2018 Mar 5. PubMed PMID: 29419882. Szulc P. J Bone Miner https://www.ncbi.nlm.nih.gov/pubmed/29419882
10.1002/jbmr.3350. Epub 2018 Feb 23. PubMed PMID: 29194749. Longitudinal Effects of Teriparatide or Zoledronic Acid on Bone Modeling- and Remodeling-Based Formation in the SHOTZ Study. Dempster DW, Zhou H, Ruff VA, Melby TE, Alam J, … Leer más
Effect of risedronate on femoral periprosthetic bone loss following total hip replacement: A systematic review and meta-analysis.
Medicine (Baltimore). 2018 Apr;97(17):e0379. doi: 10.1097/MD.0000000000010379. Review. Ren L, Wang W. PubMed PMID: 29702983; PubMed Central PMCID: PMC5944478. https://www.ncbi.nlm.nih.gov/pubmed/29702983
Vitamin D and Calcium Supplements for Preventing Fractures.
JAMA. 2018 Apr 17;319(15):1630. doi: 10.1001/jama.2018.3892. PubMed PMID: 29677304. Jin J.
Therapy of Endocrine Disease: Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis.
Anastasilakis AD, Polyzos SA, Makras P. Eur J Endocrinol. 2018 Jul;179(1):R31-R45. doi: 10.1530/EJE-18-0056. Epub 2018 Apr 24. Review. PubMed PMID: 29691303.
Mesenchymal Stem Cells-Derived Exosomes: A Possible Therapeutic Strategy for Osteoporosis.
Li Y, Jin D, Xie W, Wen L, Chen W, Xu J, Ding J, Ren D, Xiao Z. Curr Stem Cell Res Ther. 2018;13(5):362-368. doi: 10.2174/1574888X13666180403163456. PubMed PMID: 29623851. https://www.ncbi.nlm.nih.gov/pubmed/29623851
Denosumab: A Unique Perspective on Adherence and Cost-effectiveness Compared With Oral Bisphosphonates in Osteoporosis Patients.
Morizio P, Burkhart JI, Ozawa S. Ann Pharmacother. 2018 Apr 1:1060028018768808. doi: 10.1177/1060028018768808. [Epub ahead of print] PubMed PMID: 29616561.
Bisphosphonate therapy for spinal osteoporosis in Hajdu-Cheney syndrome – new data and literature review.
Pittaway JFH, Harrison C, Rhee Y, Holder-Espinasse M, Fryer AE, Cundy T, Drake WM, Irving MD. Orphanet J Rare Dis. 2018 Apr 4;13(1):47. doi: 10.1186/s13023-018-0795-5. PubMed PMID: 29618366; PubMed Central PMCID: PMC5885380.
Is calcifediol better than cholecalciferol for vitamin D supplementation?
Osteoporos Int. 2018 Apr 30. doi:10.1007/s00198-018-4520 Quesada-Gomez JM, Bouillon R. https://www.ncbi.nlm.nih.gov/pubmed/29713796
Identifying Potential Therapeutics for Osteoporosis by Exploiting the Relationship between Mevalonate Pathway and Bone Metabolism.
Wan Hasan WN, Chin KY, Jolly JJ, Abd Ghafar N, Soelaiman IN. Endocr Metab Immune Disord Drug Targets. 2018 Apr 23. doi: 10.2174/1871530318666180423122409. [Epub ahead of print] PubMed PMID: 29683099.
